bdp 12 has been researched along with Schizophrenia in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (88.89) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Broberg, BV; Dias, R; Glenthøj, BY; Larsen, DB; Olsen, CK | 1 |
Begemann, MJ; Leucht, S; Sommer, IE; Temmerman, A | 1 |
Danysz, W | 1 |
Egan, MF; Goldberg, TE; Knable, MB; Marenco, S; McClure, RK; Weinberger, DR; Winterer, G | 1 |
Ballew, N | 1 |
Tiihonen, J; Tuominen, HJ; Wahlbeck, K | 1 |
Black, MD | 1 |
Freudenreich, O; Goff, DC; Green, MF; Johnson, SA; Lamberti, JS; Leon, AC; Manschreck, T; Miller, AL; Patel, J | 1 |
Berman, I; Goff, DC; Herz, L; Johnson, SA; Leahy, L; Leon, AC; Lynch, G; Posever, T | 1 |
4 review(s) available for bdp 12 and Schizophrenia
Article | Year |
---|---|
Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review.
Topics: Antipsychotic Agents; Brief Psychiatric Rating Scale; Citalopram; Clozapine; Dioxoles; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Fructose; Humans; Lamotrigine; Piperidines; Psychiatric Status Rating Scales; Psychotropic Drugs; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Sulpiride; Topiramate; Treatment Outcome; Triazines | 2012 |
Positive modulators of AMPA receptors as a potential treatment for schizophrenia.
Topics: Animals; Clinical Trials as Topic; Dioxoles; Drug Industry; Excitatory Amino Acid Agonists; Humans; Piperidines; Receptors, AMPA; Schizophrenia | 2002 |
Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis.
Topics: Clozapine; Cycloserine; Dioxoles; Drug Synergism; Drug Therapy, Combination; Excitatory Amino Acid Agents; Glycine; Humans; Hydro-Lyases; Molindone; Piperidines; Schizophrenia | 2005 |
Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data.
Topics: Alzheimer Disease; Animals; Benzothiadiazines; Cognition; Dioxoles; Humans; Long-Term Potentiation; Memory; Neuroprotective Agents; Piperidines; Protein Subunits; Receptors, AMPA; Schizophrenia | 2005 |
3 trial(s) available for bdp 12 and Schizophrenia
Article | Year |
---|---|
Preliminary experience with an ampakine (CX516) as a single agent for the treatment of schizophrenia: a case series.
Topics: Adult; Antipsychotic Agents; Dioxoles; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperidines; Psychotic Disorders; Schizophrenia | 2002 |
A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition Disorders; Dioxoles; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Pilot Projects; Piperidines; Psychiatric Status Rating Scales; Psychomotor Performance; Risperidone; Sample Size; Schizophrenia; Schizophrenic Psychology | 2008 |
A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia.
Topics: Adult; Antipsychotic Agents; Attention; Clozapine; Cognition; Dioxoles; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Memory; Middle Aged; Pilot Projects; Piperidines; Psychological Tests; Schizophrenia | 2001 |
2 other study(ies) available for bdp 12 and Schizophrenia
Article | Year |
---|---|
Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia--sub-chronic and early postnatal PCP treatment in attentional set-shifting.
Topics: Animals; Antipsychotic Agents; Attention; Dioxoles; Disease Models, Animal; Dose-Response Relationship, Drug; Imidazoles; Indoles; Male; Phencyclidine; Piperidines; Rats; Schizophrenia | 2009 |
Cortex Pharmaceuticals, Inc. Maintaining brain function goes a long way.
Topics: Animals; Brain; Cognition Disorders; Dioxoles; Drug Industry; Humans; Piperidines; Receptors, AMPA; Schizophrenia | 2003 |